Related Experiment Video
Updated: May 30, 2026
08:05
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Aldosterone promotes atrial fibrillation.
Jan-Christian Reil1, Mathias Hohl, Simina Selejan
1Klinik für Innere Medizin III (Kardiologie, Angiologie, Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Straße, D-66421 Homburg/Saar, Germany. reil@med-in.uni-saarland.de
European Heart Journal
|August 6, 2011
Summary
Aldosterone directly promotes atrial fibrillation by causing fibrosis and conduction issues, independent of blood pressure changes. This research highlights aldosterone
Area of Science:
- Cardiology
- Endocrinology
- Electrophysiology
Background:
- Hyperaldosteronism is linked to a higher incidence of atrial fibrillation (AF).
- The exact mechanism, whether hemodynamic or direct aldosterone action, remains unclear.
- Understanding aldosterone's direct impact on atrial tissue is crucial for AF prevention.
Purpose of the Study:
- To investigate the load-independent effects of aldosterone on atrial structure and electrophysiology.
- To establish a model demonstrating aldosterone's direct role in promoting atrial arrhythmias.
Main Methods:
- Aldosterone was administered to rats via osmotic mini-pumps for 8 weeks.
- In vivo ECG, AF inducibility, and atrial pressures were measured.
- Isolated working hearts allowed assessment of ventricular function and atrial electrophysiology, including mapping and refractory period determination; histological analysis of atrial tissue was also performed.
Main Results:
- Aldosterone administration led to inducible atrial arrhythmias in all treated rats.
- Histological analysis revealed increased atrial fibrosis, myocyte hypertrophy, and reduced matrix metalloproteinase 13 activity.
- Conduction disturbances in the atria were observed, while ventricular function and atrial pressures remained unchanged.
Conclusions:
- Aldosterone directly induces a substrate for atrial arrhythmias, characterized by fibrosis and conduction abnormalities.
- This effect is independent of hemodynamic alterations, implicating aldosterone as a direct proarrhythmic factor.
- The findings suggest potential therapeutic strategies for AF prevention targeting aldosterone's direct atrial effects.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...